by Bill DuBois
The life sciences supply chain starts with a miracle
Is there a more challenging industry than life sciences? In a recent Forbes interview on why it’s so hard to bring tech into pharma, Vas Narasimhan, Chief Executive Officer of Novartis AG pointed out that only one in twenty drugs make it out of clinical trials.
One in twenty. A rate that hasn’t increased in over a decade. The only thing that has increased are the costs. Everything we talk about in supply chain starts with discovering that product you can market and sell. For those in consumer-packaged goods,Read the rest of this article by one of our favorite contributors who provide some of the best supply chain content in the industry.